Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Hyperplasia | 6 | 2017 | 522 | 1.460 |
Why?
|
Prostate | 5 | 2017 | 1743 | 1.130 |
Why?
|
Metformin | 4 | 2017 | 827 | 0.880 |
Why?
|
3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 3 | 2017 | 62 | 0.880 |
Why?
|
Prostatic Diseases | 1 | 2017 | 55 | 0.610 |
Why?
|
Epigenesis, Genetic | 2 | 2017 | 3614 | 0.490 |
Why?
|
DNA Methylation | 4 | 2017 | 4269 | 0.480 |
Why?
|
Cell Proliferation | 7 | 2017 | 10455 | 0.470 |
Why?
|
Estradiol | 2 | 2018 | 2021 | 0.460 |
Why?
|
Antineoplastic Agents, Phytogenic | 2 | 2015 | 623 | 0.410 |
Why?
|
Urinary Bladder Diseases | 1 | 2012 | 166 | 0.400 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2012 | 265 | 0.390 |
Why?
|
Somatomedins | 1 | 2011 | 192 | 0.380 |
Why?
|
Urinary Bladder, Overactive | 1 | 2012 | 104 | 0.380 |
Why?
|
Neovascularization, Pathologic | 3 | 2015 | 2639 | 0.330 |
Why?
|
Growth Hormone | 1 | 2011 | 703 | 0.320 |
Why?
|
Aromatase | 2 | 2018 | 146 | 0.300 |
Why?
|
Testosterone | 1 | 2017 | 2391 | 0.290 |
Why?
|
Membrane Proteins | 3 | 2018 | 7862 | 0.280 |
Why?
|
Aloe | 1 | 2005 | 2 | 0.270 |
Why?
|
Radiation-Protective Agents | 1 | 2005 | 89 | 0.260 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2017 | 4400 | 0.260 |
Why?
|
Plants, Medicinal | 1 | 2005 | 167 | 0.250 |
Why?
|
Angiogenesis Inhibitors | 1 | 2015 | 2037 | 0.250 |
Why?
|
Drugs, Chinese Herbal | 1 | 2005 | 145 | 0.230 |
Why?
|
Urinary Bladder Neoplasms | 3 | 2018 | 2196 | 0.190 |
Why?
|
Polysaccharides | 1 | 2005 | 1050 | 0.160 |
Why?
|
Cell Line, Transformed | 2 | 2017 | 897 | 0.150 |
Why?
|
Dihydrotestosterone | 1 | 2017 | 188 | 0.150 |
Why?
|
Cyclin D | 1 | 2017 | 70 | 0.150 |
Why?
|
Estrogen Receptor alpha | 2 | 2018 | 575 | 0.140 |
Why?
|
Texas | 1 | 2017 | 394 | 0.140 |
Why?
|
Phosphorylation | 2 | 2017 | 8416 | 0.140 |
Why?
|
Matrix Attachment Region Binding Proteins | 1 | 2015 | 44 | 0.130 |
Why?
|
Receptor, IGF Type 1 | 1 | 2017 | 390 | 0.120 |
Why?
|
Stromal Cells | 2 | 2017 | 1350 | 0.120 |
Why?
|
Cell Cycle | 2 | 2017 | 2960 | 0.120 |
Why?
|
Cell Cycle Proteins | 1 | 2005 | 3433 | 0.120 |
Why?
|
Proto-Oncogene Proteins c-sis | 2 | 2011 | 251 | 0.110 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2018 | 1157 | 0.110 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2015 | 705 | 0.110 |
Why?
|
Signal Transduction | 8 | 2018 | 23355 | 0.110 |
Why?
|
Citrates | 1 | 2013 | 132 | 0.110 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2017 | 1213 | 0.110 |
Why?
|
Intra-Abdominal Fat | 1 | 2018 | 590 | 0.110 |
Why?
|
Diabetes Mellitus | 1 | 2011 | 5702 | 0.110 |
Why?
|
Transfection | 2 | 2017 | 5884 | 0.110 |
Why?
|
Prostatectomy | 2 | 2018 | 1858 | 0.110 |
Why?
|
Myosin Light Chains | 1 | 2012 | 121 | 0.110 |
Why?
|
Genetic Heterogeneity | 1 | 2015 | 727 | 0.100 |
Why?
|
Promoter Regions, Genetic | 4 | 2017 | 5863 | 0.100 |
Why?
|
RNA Interference | 2 | 2017 | 2899 | 0.100 |
Why?
|
Cholestenone 5 alpha-Reductase | 1 | 2011 | 21 | 0.100 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2013 | 290 | 0.100 |
Why?
|
Cadherins | 1 | 2015 | 901 | 0.100 |
Why?
|
Estrogens | 1 | 2018 | 1561 | 0.090 |
Why?
|
rho-Associated Kinases | 1 | 2012 | 279 | 0.090 |
Why?
|
Urinary Bladder | 2 | 2018 | 1153 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 2011 | 286 | 0.090 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2012 | 563 | 0.090 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2011 | 216 | 0.090 |
Why?
|
Autophagy | 1 | 2018 | 1295 | 0.090 |
Why?
|
Lymphatic Metastasis | 1 | 2018 | 2897 | 0.090 |
Why?
|
Glutamine | 1 | 2013 | 574 | 0.090 |
Why?
|
Neoplasms | 2 | 2015 | 21507 | 0.090 |
Why?
|
Blood Vessels | 1 | 2015 | 1126 | 0.080 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2017 | 2015 | 0.080 |
Why?
|
Tumor Microenvironment | 2 | 2018 | 3508 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 11699 | 0.080 |
Why?
|
Erythropoietin | 1 | 2011 | 724 | 0.070 |
Why?
|
Muscle Contraction | 1 | 2012 | 1240 | 0.070 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 1116 | 0.070 |
Why?
|
Epithelial Cells | 2 | 2017 | 3671 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2018 | 8400 | 0.070 |
Why?
|
Up-Regulation | 2 | 2015 | 4205 | 0.070 |
Why?
|
Cyclin B1 | 1 | 2005 | 51 | 0.070 |
Why?
|
Fibrosarcoma | 1 | 2007 | 348 | 0.070 |
Why?
|
Cyclin B | 1 | 2005 | 108 | 0.070 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2007 | 600 | 0.060 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2007 | 625 | 0.060 |
Why?
|
Antigens, CD | 1 | 2015 | 4024 | 0.060 |
Why?
|
Transcriptional Activation | 1 | 2011 | 1783 | 0.060 |
Why?
|
Male | 13 | 2018 | 349022 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9314 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2014 | 2455 | 0.060 |
Why?
|
X-Rays | 1 | 2005 | 300 | 0.060 |
Why?
|
Prostatic Neoplasms | 2 | 2018 | 10999 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2727 | 0.060 |
Why?
|
Cells, Cultured | 2 | 2017 | 19220 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2901 | 0.060 |
Why?
|
Hematopoiesis | 1 | 2011 | 2049 | 0.050 |
Why?
|
Humans | 18 | 2018 | 739398 | 0.050 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2014 | 2185 | 0.050 |
Why?
|
Animals | 9 | 2018 | 168368 | 0.050 |
Why?
|
Cell Line, Tumor | 5 | 2015 | 16646 | 0.050 |
Why?
|
Immunotherapy | 1 | 2015 | 4391 | 0.040 |
Why?
|
Mice | 7 | 2018 | 81002 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2014 | 4216 | 0.040 |
Why?
|
Mice, Nude | 2 | 2015 | 3692 | 0.040 |
Why?
|
Radiation Injuries | 1 | 2005 | 1161 | 0.040 |
Why?
|
Carcinoma, Renal Cell | 1 | 2013 | 3101 | 0.040 |
Why?
|
Isoenzymes | 2 | 2014 | 1720 | 0.040 |
Why?
|
Mice, Knockout | 1 | 2012 | 14558 | 0.040 |
Why?
|
Risk Assessment | 1 | 2018 | 23294 | 0.040 |
Why?
|
Lung Neoplasms | 2 | 2014 | 12985 | 0.040 |
Why?
|
Disease Models, Animal | 2 | 2012 | 18003 | 0.030 |
Why?
|
Disease Progression | 3 | 2018 | 13237 | 0.030 |
Why?
|
Aging | 1 | 2015 | 8613 | 0.030 |
Why?
|
Urothelium | 1 | 2018 | 277 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6516 | 0.030 |
Why?
|
Adipogenesis | 1 | 2018 | 356 | 0.030 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2005 | 2948 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2018 | 12237 | 0.030 |
Why?
|
Mice, SCID | 2 | 2011 | 2716 | 0.030 |
Why?
|
Transcription Factor RelA | 1 | 2015 | 276 | 0.030 |
Why?
|
Aromatase Inhibitors | 1 | 2018 | 490 | 0.030 |
Why?
|
Sex Factors | 2 | 2018 | 10398 | 0.030 |
Why?
|
Survival Analysis | 2 | 2018 | 10247 | 0.030 |
Why?
|
Carboxylic Acids | 1 | 2013 | 99 | 0.030 |
Why?
|
Obesity | 1 | 2015 | 12643 | 0.030 |
Why?
|
Cystectomy | 1 | 2018 | 675 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13635 | 0.030 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2013 | 361 | 0.030 |
Why?
|
Methylation | 1 | 2015 | 1106 | 0.030 |
Why?
|
Carbon Isotopes | 1 | 2013 | 470 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2015 | 607 | 0.030 |
Why?
|
Prognosis | 3 | 2018 | 28901 | 0.030 |
Why?
|
Extracellular Fluid | 1 | 2013 | 166 | 0.030 |
Why?
|
Aged | 7 | 2018 | 162698 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2018 | 11347 | 0.020 |
Why?
|
Carcinoma, Lewis Lung | 1 | 2011 | 115 | 0.020 |
Why?
|
Cell Line | 1 | 2005 | 15987 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2015 | 5148 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1654 | 0.020 |
Why?
|
Middle Aged | 7 | 2018 | 212863 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2084 | 0.020 |
Why?
|
Liver | 1 | 2005 | 7449 | 0.020 |
Why?
|
Adiposity | 1 | 2018 | 1801 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2015 | 3562 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2013 | 2184 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2018 | 21863 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2015 | 3453 | 0.020 |
Why?
|
CpG Islands | 1 | 2011 | 1163 | 0.020 |
Why?
|
MAP Kinase Signaling System | 1 | 2014 | 1522 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2018 | 38942 | 0.020 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2007 | 250 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2014 | 3603 | 0.020 |
Why?
|
Pericytes | 1 | 2007 | 291 | 0.020 |
Why?
|
Capillaries | 1 | 2007 | 767 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2015 | 4832 | 0.020 |
Why?
|
Survival Rate | 1 | 2018 | 12761 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12328 | 0.010 |
Why?
|
Down-Regulation | 1 | 2011 | 2999 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4743 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2013 | 3757 | 0.010 |
Why?
|
Anemia | 1 | 2011 | 1498 | 0.010 |
Why?
|
Female | 5 | 2018 | 378853 | 0.010 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2007 | 1504 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5830 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2015 | 57650 | 0.010 |
Why?
|
Apoptosis | 1 | 2015 | 9714 | 0.010 |
Why?
|
Age Factors | 1 | 2015 | 18349 | 0.010 |
Why?
|
Gene Expression | 1 | 2011 | 7788 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2015 | 9122 | 0.010 |
Why?
|
Models, Biological | 1 | 2013 | 9609 | 0.010 |
Why?
|
Cell Movement | 1 | 2007 | 5221 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2007 | 4454 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 40050 | 0.010 |
Why?
|
Rats | 1 | 2007 | 24270 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2018 | 76631 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2015 | 62693 | 0.010 |
Why?
|
Concepts
(171)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_